See more : Lodestar Minerals Limited (LSR.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Zhongchao Inc. (ZCMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhongchao Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- AI Energy Public Company Limited (AIE.BK) Income Statement Analysis – Financial Results
- Invinity Energy Systems plc (IESVF) Income Statement Analysis – Financial Results
- Shenzhen Comix Group Co., Ltd. (002301.SZ) Income Statement Analysis – Financial Results
- Authentic Equity Acquisition Corp. (AEACW) Income Statement Analysis – Financial Results
- Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) Income Statement Analysis – Financial Results
Zhongchao Inc. (ZCMD)
About Zhongchao Inc.
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 19.43M | 14.15M | 16.30M | 17.99M | 14.88M | 12.87M | 9.82M |
| Cost of Revenue | 10.92M | 7.79M | 6.86M | 6.12M | 4.66M | 4.46M | 3.97M |
| Gross Profit | 8.51M | 6.36M | 9.44M | 11.87M | 10.23M | 8.41M | 5.85M |
| Gross Profit Ratio | 43.80% | 44.92% | 57.92% | 65.99% | 68.72% | 65.36% | 59.56% |
| Research & Development | 514.41K | 411.52K | 758.88K | 816.55K | 864.32K | 1.45M | 943.25K |
| General & Administrative | 6.70M | 6.80M | 5.86M | 3.12M | 2.52M | 1.43M | 1.14M |
| Selling & Marketing | 6.71M | 2.10M | 3.14M | 3.44M | 3.20M | 2.26M | 2.72M |
| SG&A | 13.41M | 8.90M | 9.00M | 6.57M | 5.72M | 3.69M | 3.85M |
| Other Expenses | 7.87M | 262.44K | 34.00K | 305.57K | 534.02K | 37.36K | 275.02K |
| Operating Expenses | 21.80M | 9.31M | 9.76M | 7.38M | 6.58M | 5.13M | 4.80M |
| Cost & Expenses | 32.72M | 17.11M | 16.62M | 13.50M | 11.24M | 9.59M | 8.77M |
| Interest Income | 237.05K | 142.01K | 175.99K | 146.97K | 211.48K | 191.61K | 17.33K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 923.61K | 730.31K | 679.79K | 403.01K | 240.51K | 28.78K | 16.27K |
| EBITDA | -4.90M | -2.22M | 382.24K | 4.49M | 3.64M | 3.30M | 1.06M |
| EBITDA Ratio | -25.23% | -15.72% | 2.35% | 27.32% | 26.23% | 25.75% | 10.85% |
| Operating Income | -13.28M | -2.95M | -320.74K | 4.49M | 3.64M | 3.27M | 1.05M |
| Operating Income Ratio | -68.35% | -20.88% | -1.97% | 24.96% | 24.47% | 25.45% | 10.68% |
| Total Other Income/Expenses | 1.31M | 404.46K | 209.99K | 452.53K | 745.50K | 228.97K | 292.35K |
| Income Before Tax | -11.98M | -2.55M | -110.75K | 4.94M | 4.39M | 3.50M | 1.34M |
| Income Before Tax Ratio | -61.63% | -18.02% | -0.68% | 27.47% | 29.48% | 27.23% | 13.66% |
| Income Tax Expense | -669.76K | 272.31K | -349.42K | 484.79K | 387.14K | 502.13K | -153.95K |
| Net Income | -11.34M | -2.82M | 238.67K | 4.46M | 4.05M | 3.02M | 1.53M |
| Net Income Ratio | -58.33% | -19.94% | 1.46% | 24.78% | 27.19% | 23.47% | 15.58% |
| EPS | -4.35 | -1.09 | 0.10 | 1.83 | 1.87 | 1.45 | 0.78 |
| EPS Diluted | -4.35 | -1.09 | 0.10 | 1.83 | 1.87 | 1.45 | 0.78 |
| Weighted Avg Shares Out | 2.60M | 2.60M | 2.49M | 2.44M | 2.16M | 2.08M | 1.96M |
| Weighted Avg Shares Out (Dil) | 2.60M | 2.60M | 2.49M | 2.44M | 2.16M | 2.08M | 1.96M |
Why Is Zhongchao (ZCMD) Stock Up 52% Today?
Why Is Zhongchao (ZCMD) Stock Up 103% Today?
Why Is Zhongchao (ZCMD) Stock Up 40% Today?
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
Why Is Zhongchao (ZCMD) Stock Up 15% Today?
Zhongchao Inc. Announces 1-for-10 Share Consolidation
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management
Source: https://incomestatements.info
Category: Stock Reports